Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.010.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.85% | 28.30% | 90.21% | -22.41% | -19.71% |
| Total Receivables | 42.56% | 142.27% | 8.46% | -10.22% | -13.40% |
| Inventory | 181.79% | -- | -- | -- | -- |
| Prepaid Expenses | -32.96% | -29.96% | 244.52% | -68.25% | 28.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -91.02% | -0.89% | 0.00% |
| Total Current Assets | 71.78% | 29.13% | 87.73% | -23.66% | -18.20% |
|
|
|||||
| Total Current Assets | 71.78% | 29.13% | 87.73% | -23.66% | -18.20% |
| Net Property, Plant & Equipment | -9.70% | 51.85% | -13.53% | -11.42% | -10.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 70.60% | 29.41% | 85.06% | -23.38% | -18.03% |
|
|
|||||
| Total Accounts Payable | 77.56% | 77.35% | 8.71% | 22.82% | 23.40% |
| Total Accrued Expenses | 24.01% | -7.52% | 17.43% | -41.82% | 78.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.85% | 33.95% | -6.21% | -4.98% | -5.08% |
| Total Finance Division Other Current Liabilities | 78.22% | -- | -- | -- | -- |
| Total Other Current Liabilities | 78.22% | -- | -- | -- | -- |
| Total Current Liabilities | 49.82% | 32.83% | 13.37% | -28.39% | 59.52% |
|
|
|||||
| Total Current Liabilities | 49.82% | 32.83% | 13.37% | -28.39% | 59.52% |
| Long-Term Debt | 138.33% | 1.75% | 1.75% | 1.75% | 1.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -32.10% | 3.85% | -19.03% | -15.44% | -13.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -13.25% | -- | -- | -- | -- |
| Total Liabilities | 119.64% | 6.76% | 3.20% | -4.18% | 9.07% |
|
|
|||||
| Common Stock & APIC | 4.88% | 10.23% | 14.40% | 0.41% | 0.46% |
| Retained Earnings | -6.05% | -4.21% | -2.97% | -3.34% | -5.65% |
| Treasury Stock & Other | 0.00% | 0.00% | 4.85% | 0.00% | 0.00% |
| Total Common Equity | -13.69% | 103.74% | 215.53% | -189.81% | -146.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.69% | 103.74% | 215.53% | -189.81% | -146.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.69% | 103.74% | 215.53% | -189.81% | -146.57% |
|
|
|||||